The uselessness of CD44 levels in synovial sarcoma prognosis has also been supported by Zhou et al., where stem cell-associated markers (CD133, CD29, CD44, nestin) and ALDH1 were characterized immunohistochemically in 20 synovial sarcomas. The gene discussed is ALDH1A1; the disease is synovial sarcoma.